# Beyond the Th2 paradigm: CD4+ cytotoxic T lymphocytes as key drivers of tissue damage and fibrosis in IgG4-related disease

## TL;DR

This paper explores how CD4+ cytotoxic T lymphocytes contribute to tissue damage and fibrosis in IgG4-related disease, challenging the traditional Th2 paradigm.

## Contribution

The paper introduces CD4+ cytotoxic T lymphocytes as a novel key driver of IgG4-related disease pathology.

## Key findings

- CD4+ cytotoxic T lymphocytes are extensively infiltrated in IgG4-related disease lesions.
- These cells have dual cytotoxic and profibrotic properties contributing to tissue damage.
- CD4+ cytotoxic T lymphocytes are proposed as potential biomarkers and therapeutic targets.

## Abstract

IgG4-related disease (IgG4-RD) is a distinctive immune-mediated disorder characterized by multi-organ involvement, dense IgG4+ plasma cell infiltration, and storiform fibrosis. While pathogenesis has traditionally been attributed primarily to T helper type(Th) 2 cytokines (e.g., Interleukin(IL)-4/IL-10), this mechanism insufficiently accounts for the observed tissue destruction and progressive fibrosis. Emerging data highlight the extensive, oligoclonally expanded infiltration of CD4+ cytotoxic T lymphocytes (CTLs) deep within lesions. These cells possess dual cytotoxic and profibrotic properties. This review systematically elucidates the role of CD4+ CTLs as a distinct lineage and core effector population. We detail how these cells mediate the pathology linking chronic inflammation and fibrosis through direct cytotoxicity, secretion of profibrotic factors, and complex B-cell interactions. Finally, we assess the clinical potential of CD4+ CTLs as biomarkers of disease activity and as novel therapeutic targets.